Vor Biopharma Inc.Vor Biopharma Inc.Vor Biopharma Inc.

Vor Biopharma Inc.

No trades
See on Supercharts

VOR fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Cambridge, MA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
VOR has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company